Table 2.
Ligand interactions report for the binding of adenosine and kinetin to A2A-R receptor.
Ligand | Receptor | Interaction | Distance | E (kcal/mol) |
---|---|---|---|---|
Adenosine interactions to A2A-R | ||||
O5′ 1 | O HOH 2017 (A) | H-donor | 2.73 | − 1.0 |
O3′ 6 | OG SER 277 (A) | H-donor | 2.79 | − 1.8 |
O2′ 8 | O HOH 2016 (A) | H-donor | 2.74 | − 1.4 |
N6 15 | OE2 GLU 169 (A) | H-donor | 3.06 | − 4.3 |
N6 15 | OD1 ASN 253 (A) | H-donor | 3.11 | − 3.3 |
O5′ 1 | O HOH 2017 (A) | H-acceptor | 2.73 | − 1.0 |
O3′ 6 | OG SER 277 (A) | H-acceptor | 2.79 | − 1.7 |
O2′ 8 | O HOH 2016 (A) | H-acceptor | 2.74 | − 1.0 |
N7 12 | ND2 ASN 253 (A) | H-acceptor | 3.60 | − 2.2 |
N1 16 | O HOH 2018 (A) | H-acceptor | 2.72 | − 1.3 |
N3 18 | O HOH 2016 (A) | H-acceptor | 3.04 | − 2.4 |
5-ring | 6-ring PHE 168 (A) | pi-pi | 3.61 | − 0.0 |
6-ring | 6-ring PHE 168 (A) | pi-pi | 3.80 | − 0.0 |
Kinetin interactions to A2A-R | ||||
CAM 1 | CG2 THR 88 (A) | H-donor | 3.96 | − 0.5 |
CAO 3 | CG2 THR 88 (A) | H-donor | 3.70 | − 0.7 |
CAN 5 | CG2 VAL 84 (A) | H-donor | 3.56 | − 0.8 |
CAP 9 | CD2 LEU 249 (A) | H-donor | 4.03 | − 0.6 |
C2 15 | CG LEU 249 (A) | H-donor | 3.50 | − 0.5 |
N3 17 | OD1 ASN 253 (A) | H-donor | 2.83 | − 3.6 |
N7 21 | CD1 ILE 274 (A) | H-donor | 3.52 | − 0.5 |
N9 24 | CG GLU 169 (A) | H-donor | 3.48 | − 0.7 |
N9 24 | OE2 GLU 169 (A) | H-donor | 2.80 | − 4.4 |
N9 24 | CE MET 270 (A) | H-donor | 3.33 | − 0.9 |
CAM 1 | CG2 THR 88 (A) | H-acceptor | 3.96 | − 0.5 |
CAO 3 | CG2 THR 88 (A) | H-acceptor | 3.70 | − 0.7 |
CAN 5 | CG2 VAL 84 (A) | H-acceptor | 3.56 | − 0.8 |
CAP 9 | CD2 LEU 249 (A) | H-acceptor | 4.03 | − 0.6 |
N6 12 | O HOH 2016 (A) | H-acceptor | 3.02 | − 1.3 |
C2 15 | CG LEU 249 (A) | H-acceptor | 3.50 | − 0.5 |
N7 21 | CD1 ILE 274 (A) | H-acceptor | 3.52 | − 0.5 |
N7 21 | O HOH 2016 (A) | H-acceptor | 2.86 | − 3.0 |
N9 24 | CG GLU 169 (A) | H-acceptor | 3.48 | − 0.7 |
N9 24 | CE MET 270 (A) | H-acceptor | 3.33 | − 0.9 |
5-ring | NE2 HIS 278 (A) | pi-H | 3.36 | − 1.4 |